Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

271 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Histiocytic Disorders, Malignant trial results

Completed

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

NCT00059995

Conditions
Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +19 more
Locations
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Northside Hospital Cancer Center Atlanta, Georgia, United States
  • Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

PET Study in Patients With Non-Hodgkin Lymphoma

NCT00712556

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions